Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol
- DOI
- 10.1136/bmjopen-2025-115512
- Published
- 2026-06
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-115512,
title = {Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol},
author = {Christian Domingo and Gema Monteagudo and Francisco Ramos-Lima and Marta Alegría and Gabriel Niza and Marta Robles and Javier Domínguez-Ortega},
year = {2026},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2025-115512},
url = {https://doi.org/10.1136/bmjopen-2025-115512}
}RIS
TY - JOUR TI - Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol AU - Christian Domingo AU - Gema Monteagudo AU - Francisco Ramos-Lima AU - Marta Alegría AU - Gabriel Niza AU - Marta Robles AU - Javier Domínguez-Ortega PY - 2026 JO - BMJ Open DO - 10.1136/bmjopen-2025-115512 UR - https://doi.org/10.1136/bmjopen-2025-115512 ER -
APA
Domingo, C., Monteagudo, G., Ramos-Lima, F., Alegría, M., Niza, G., Robles, M., & Domínguez-Ortega, J. (2026). Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol. BMJ Open. https://doi.org/10.1136/bmjopen-2025-115512
Source records
- crossref · retrieved 2026-09-26T01:47:48.717Z